Arcutis Biotherapeutics Market Sentiment

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,123.80+0.24%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Premium

Arcutis Biotherapeutics Inc

ARQTNASDAQ

Trade with Public

$26.58

2.098.53%

Last update: Oct 9, 4:00 PM

$24.94

0.451.84%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Arcutis Biotherapeutics Market Sentiment - Benzinga

Arcutis Biotherapeutics Market Sentiment

Market sentiment signals for Arcutis Biotherapeutics (ARQT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 18.4% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

11 analysts

Options Flow (P/C)

—

Avg Consensus PT

$29

+8.2%

Highest Price Target

$40

+48.7%

Needham

Lowest Price Target

-70.3%

HC Wainwright & Co.

Short Interest

18.4%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 6, 2026	Morgan Stanley	Vikram Purohit—	+41.3%	$34 → $38	Maintained	Overweight
Aug 6, 2026	Guggenheim	Seamus Fernandez—	+41.3%	$35 → $38	Maintained	Buy
Aug 6, 2026	Needham	Serge Belanger—	+48.7%	$36 → $40	Maintained	Buy
May 7, 2026	Needham	Serge Belanger—	+33.8%	$36 → $36	Maintained	Buy
Mar 2, 2026	Mizuho	Uy Ear—	+30.1%	$37 → $35	Maintained	Outperform
Feb 27, 2026	Guggenheim	Seamus Fernandez—	+30.1%	$34 → $35	Maintained	Buy
Feb 26, 2026	TD Cowen	Tyler Van Buren—	+30.1%	$30 → $35	Maintained	Buy
Feb 26, 2026	HC Wainwright & Co.	Douglas Tsao—	+26.4%	$30 → $34	Maintained	Buy
Feb 26, 2026	Needham	Serge Belanger—	+33.8%	$31 → $36	Maintained	Buy
Jan 26, 2026	Needham	Serge Belanger—	+15.2%	$30 → $31	Maintained	Buy
Nov 28, 2025	Mizuho	Uy Ear—	+37.5%	$32 → $37	Maintained	Outperform
Oct 30, 2025	Goldman Sachs	Richard Law—	+7.8%	$19 → $29	Maintained	Neutral
Oct 28, 2025	Needham	Serge Belanger—	+11.5%	$22 → $30	Maintained	Buy
Aug 7, 2025	Needham	Serge Belanger—	-18.2%	$20 → $22	Maintained	Buy
Jul 25, 2025	Goldman Sachs	Richard Law—	-33.1%	$18	Initiate	Neutral
May 23, 2025	Needham	Serge Belanger—	-25.7%	$20 → $20	Maintained	Buy
Apr 9, 2025	Needham	Serge Belanger—	-25.7%	$20 → $20	Maintained	Buy
Apr 3, 2025	Guggenheim	Seamus Fernandez—	—	—	Maintained	Buy
Apr 3, 2025	HC Wainwright & Co.	Douglas Tsao—	-29.4%	$19 → $19	Maintained	Buy
Apr 3, 2025	Needham	Serge Belanger—	-25.7%	$20 → $20	Maintained	Buy
Mar 11, 2025	Jefferies	Kambiz Yazdi—	-29.4%	$16 → $19	Maintained	Buy
Feb 27, 2025	Goldman Sachs	Jonathan Block—	-44.2%	$13 → $15	Maintained	Neutral
Feb 26, 2025	HC Wainwright & Co.	Douglas Tsao—	-29.4%	$19 → $19	Maintained	Buy
Feb 26, 2025	Mizuho	Uy Ear—	-21.9%	$20 → $21	Maintained	Outperform
Feb 26, 2025	Needham	Serge Belanger—	-25.7%	$20 → $20	Maintained	Buy